Carola Reindl

Point mutations in the juxtamembrane domain of FLT3 define a new class of activating mutations in AML

Carola Reindl, Ksenia Bagrintseva, Sridhar Vempati et al. · Blood · 2006 · 129 citations · Full text

Medicine, Genetics, Molecular Genetics +8

CBL Exon 8/9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor/11q Deletion Acute Myeloid Leukemia/Myelodysplastic Syndrome Subtypes

Carola Reindl, Hilmar Quentmeier, Konstantin Petropoulos et al. · Clinical Cancer Research · 2009 · 117 citations

Medicine, Genetics, Oncology +17

FLT3-ITD-TKD dual mutants associated with AML confer resistance to FLT3 PTK inhibitors and cytotoxic agents by overexpression of Bcl-x(L)

Ksenia Bagrintseva, Stefanie Geisenhof, Ruth Kern et al. · Blood · 2004 · 108 citations · Full text

Medicine, Oncology, Pharmacology +16

Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3

Bob Argiropoulos, Eric Yung, Ping Xiang et al. · Blood · 2010 · 37 citations

Life Sciences, Cell Biology, Molecular Biology +17

Arginine 595 is duplicated in patients with acute leukemias carrying internal tandem duplications of FLT3 and modulates its transforming potential

Sridhar Vempati, Carola Reindl, Seshu Kumar Kaza et al. · Blood · 2007 · 30 citations · Full text

Life Sciences, Genetics, Molecular Genetics +10